|
1
|
Huang J, Shelton JM, Richardson JA, Kamm
KE and Stull JT: Myosin regulatory light chain phosphorylation
attenuates cardiac hypertrophy. J Biol Chem. 283:19748–19756. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Melman YF, Shah R and Das S: MicroRNAs in
heart failure: Is the picture becoming less miRky? Circ Heart Fail.
7:203–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ikeda S, He A, Kong SW, Lu J, Bejar R,
Bodyak N, Lee KH, Ma Q, Kang PM, Golub TR and Pu WT: MicroRNA-1
negatively regulates expression of the hypertrophy-associated
calmodulin and Mef2a genes. Mol Cell Biol. 29:2193–2204. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elia L, Contu R, Quintavalle M, Varrone F,
Chimenti C, Russo MA, Cimino V, De Marinis L, Frustaci A, Catalucci
D and Condorelli G: Reciprocal regulation of microRNA-1 and
insulin-like growth factor-1 signal transduction cascade in cardiac
and skeletal muscle in physiological and pathological conditions.
Circulation. 120:2377–2385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Q, Song XW, Zou J, Wang GK, Kremneva E,
Li XQ, Zhu N, Sun T, Lappalainen P, Yuan WJ, et al: Attenuation of
microRNA-1 derepresses the cytoskeleton regulatory protein
twinfilin-1 to provoke cardiac hypertrophy. J Cell Sci.
123:2444–2452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tritsch E, Mallat Y, Lefebvre F, Diguet N,
Escoubet B, Blanc J, De Windt LJ, Catalucci D, Vandecasteele G, Li
Z and Mericskay M: An SRF/miR-1 axis regulates NCX1 and annexin A5
protein levels in the normal and failing heart. Cardiovasc Res.
98:372–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karakikes I, Chaanine AH, Kang S, Mukete
BN, Jeong D, Zhang S, Hajjar RJ and Lebeche D: Therapeutic
cardiac-targeted delivery of miR-1 reverses pressure
overload-induced cardiac hypertrophy and attenuates pathological
remodeling. J Am Heart Assoc. 2:e0000782013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hou Y, Sun Y, Shan H, Li X, Zhang M, Zhou
X, Xing S, Sun H, Chu W, Qiao G and Lu Y: β-adrenoceptor regulates
miRNA expression in rat heart. Med Sci Monit. 18:BR309–BR314. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Varrone F, Gargano B, Carullo P, Di
Silvestre D, De Palma A, Grasso L, Di Somma C, Mauri P, Benazzi L,
Franzone A, et al: The circulating level of FABP3 is an indirect
biomarker of microRNA-1. J Am Coll Cardiol. 61:88–95. 2013.
View Article : Google Scholar
|
|
11
|
Wilkins BJ, De Windt LJ, Bueno OF, Braz
JC, Glascock BJ, Kimball TF and Molkentin JD: Targeted disruption
of NFATc3, but not NFATc4, reveals an intrinsic defect in
calci-neurin-mediated cardiac hypertrophic growth. Mol Cell Biol.
22:7603–7613. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilkins BJ, Dai YS, Bueno OF, Parsons SA,
Xu J, Plank DM, Jones F, Kimball TR and Molkentin JD:
Calcineurin/NFAT coupling participates in pathological, but not
physiological, cardiac hypertrophy. Circ Res. 94:110–118. 2004.
View Article : Google Scholar
|
|
13
|
Tan WQ, Wang K, Lv DY and Li PF: Foxo3a
inhibits cardiomyocyte hypertrophy through transactivating
catalase. J Biol Chem. 283:29730–29739. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reinhold MI, Abe M, Kapadia RM, Liao Z and
Naski MC: FGF18 represses noggin expression and is induced by
calcineurin. J Biol Chem. 279:38209–38219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu J, Ma L, Li C, Zhang Z, Yang G and
Zhang W: Tumor-targeting TRAIL expression mediated by miRNA
response elements suppressed growth of uveal melanoma cells. Mol
Oncol. 7:1043–1055. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma L, Liu J, Shen J, Liu L, Wu J, Li W, et
al: Expression of miR-122 mediated by adenoviral vector induces
apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther.
9:554–561. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murtaza I, Wang HX, Feng X, Alenina N,
Bader M, Prabhakar BS and Li PF: Down-regulation of catalase and
oxidative modification of protein kinase CK2 lead to the failure of
apoptosis repressor with caspase recruitment domain to inhibit
cardiomyocyte hypertrophy. J Biol Chem. 283:5996–6004. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang K, Long B, Zhou J and Li PF: MiR-9
and NFATc3 regulate myocardin in cardiac hypertrophy. J Biol Chem.
285:11903–11912. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dai H, Jia G, Liu X, Liu Z and Wang H:
Astragalus polysac-charide inhibits isoprenaline-induced cardiac
hypertrophy via suppressing Ca2+-mediated
calcineurin/NFATc3 and CaMKII signaling cascades. Environ Toxicol
Pharmacol. 38:263–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma L, Liu J, Shen J, Liu L, Wu J, Li W,
Luo J, Chen Q and Qian C: Expression of miR-122 mediated by
adenoviral vector induces apoptosis and cell cycle arrest of cancer
cells. Cancer Biol Ther. 9:554–561. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bandiera S, Pfeffer S, Baumert TF and
Zeisel MB: MiR-122-a key factor and therapeutic target in liver
disease. J Hepatol. 62:448–457. 2015. View Article : Google Scholar
|
|
22
|
Oliveira-Carvalho V, da Silva MM,
Guimarães GV, Bacal F and Bocchi EA: MicroRNAs: New players in
heart failure. Mol Biol Rep. 40:2663–2670. 2013. View Article : Google Scholar
|
|
23
|
Li J, Liu Y, Wang C, Deng T, Liang H, Wang
Y, Huang D, Fan Q, Wang X, Ning T, et al: Serum miRNA expression
profile as a prognostic biomarker of stage II/III colorectal
adenocarcinoma. Sci Rep. 5:129212015. View Article : Google Scholar : PubMed/NCBI
|
